Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJH1 in Parkinson's Disease
NCT01684475Phase 2Unknown
- Sponsor
- Alexandra Marine and General Hospital
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CLR4001 in Parkinson's disease (PD), sponsored by Alexandra Marine and General Hospital. Status: unknown.
02
Drugs
CLR4001
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01684475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01684475.